As Australia’s fastest growing allied health portfolio, Healthia (ASX: HLA) has been rapidly expanding its network of podiatry, physiotherapy and optometry clinics which have seen the promotion of 16 new Partners under their unique ownership model.
Hosted at the Hilton in Brisbane and with existing Partners in attendance, Healthia welcomed 16 new members of their Clinic Class Shareholders (CSS) program which provides allied health professionals with ownership over their clinic, or several clinics within a region. This in turn secures a profit share arrangement where exceptional leaders are rewarded for delivering outstanding patient outcomes and growing their clinic.
The event was Healthia’s first opportunity to gather en masse to celebrate the deeds of their emerging leaders with CEO Wesley Coote looking forward to making it a staple of the corporate calendar.
“With over 160 clinic class shareholders across Australia and New Zealand, the opportunity to connect, and to come together to collaborate was full of energy, and a very significant moment for Healthia,” said Coote.
“We were thrilled to celebrate this exciting milestone in the careers of our newest CCS partners, and we very much look forward to supporting them in their partnership journeys ahead.”
The opportunity to become your own boss through Healthia’s CSS ownership opportunity has been particularly popular at the entry level where Healthia has undertaken its largest ever intake of Graduates in 2022 with 164 joining the Company, up from the 63 in 2021.
Through Healthia’s industry-leading education programs, young allied health professionals can progress through their Graduate program with the aim of working up towards clinic ownership under the CSS program. The program has been most popular with the opportunity for clinicians to own their clinic while leveraging Healthia’s centralised support services that include marketing, human resources and administration.
Where Healthia’s model is most unique for an ASX-listed company is that they are able to partially fund new clinic acquisitions through their CSS program without diluting the Company’s ASX shares on issue. As a public company, the growth of clinics post-integration into Healthia has been a core driver behind new clinics seeking to enter the Healthia network.
In a recently issued business update, Coote provided financial guidance where he expects Healthia’s revenue to be in the range of $195-$200 million for FY22. This would represent an increase on the $140.4m report in FY21.
Earnings were impacted due to COVID-related lockdowns where underlying EBITDA is expected to be approximately $22.5m which is in line with FY21’s $21.5m but this was attributed to Healthia supporting its workforce throughout the pandemic where other similar businesses elected to lay off staff.
Assuming there are no further impacts from COVID, Healthia is on track to commence FY23 with an annualised portfolio of $40 million in underlying EBITDA.
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
- Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
- Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
- ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
*Owners of this website are shareholders in a company mentioned in this article and have been engaged by them to assist in investor communications
Leave a Comment
You must be logged in to post a comment.